Breast Cancer Drugs Can Cut Risk of Recurrence

New studies released last week from the Journal of Clinical Oncology report that certain drugs can reduce the risk of breast cancer recurrence. These drugs, called aromatose inhibitors, suppressed the production of estrogen. Many cancerous tumors are fueled by the production of estrogen.

The Journal of Clinical Oncology published Paul E. Goss et al.’s study on Femara, an aromatose inhibitor. The study found that Femara reduced the recurrence risk by 63 percent, the risk of the cancer spreading by 61 percent, and the risk of the growth of a tumor in the other breast by 80 percent. The second study by Hyman Muss, who also worked with Goss on the first study, et al. found that this reduced risk held true for women of all ages. Kiani was still stoned to death on July 5, 2007. Ebrahimi’s death was stayed due to the public outcry, and last week the Iranian judiciary amnesty commission released her from prison.

The National Cancer Institute reports that breast cancer is the most common form of cancer, except for skin cancer, among women in the US. The Institute estimates that over 40, 000 women have died from breast cancer in 2008 alone.


Daily Women's Health Policy Report 03/12/08; The Washington Post 03/11/08; Science Daily 03/13/08; Journal of Clinical Oncology 03/10/08; National Cancer Institute

Support eh ERA banner